China signals price cuts for cancer drugs, imports
SHANGHAI (Reuters) - China has signaled its intent to cut prices of medicines used to treat serious diseases such as cancer, part of a wider drive to reduce the cost of healthcare for patients in the world's second-biggest economy.
Aucun commentaire:
Enregistrer un commentaire